Imaging aspects of maxillomandibular bone alterations in patients with multiple myeloma treated with bisphosphonates: A systematic review

被引:0
|
作者
Gonzaga, Amanda Katarinny Goes [1 ]
Morais, Hannah Gil de Farias [1 ]
Oliveira, Camila Dayla Melo [2 ]
Campos, Magda Lyce Rodrigues [3 ]
Diaz, Carolina Raiane Leite Dourado Maranhao [2 ]
Custodio, Marcos [4 ]
Andrade, Natalia Silva [5 ]
Santana, Thalita [2 ]
机构
[1] Univ Fed Rio Grande do Norte, Dept Dent, Natal, Brazil
[2] Ceuma Univ, Postgrad Program Dent, Sao Luis, Maranhao, Brazil
[3] Univ Maranhao, Sch Dent, Sao Luis, Brazil
[4] Univ Fed Maranhao, Sch Med, Imperatriz, Brazil
[5] Univ Fed Sergipe, Dept Dent, Lagarto, Brazil
关键词
Multiple Myeloma; Bisphosphonate; BisphosphonateAssociated Osteonecrosis of the Jaw; Diagnostic Imaging; MEDICATION-RELATED OSTEONECROSIS; ASSOCIATION; JAW;
D O I
10.5624/isd.20240032
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose : Multiple myeloma (MM) is a rare cancer that is typically managed with bisphosphonates to slow bone resorption and prevent skeletal complications. This study aimed to identify imaging patterns in MM patients recei ving bisphosphonate therapy. Materials and Methods : This systematic review included studies investigating maxillomandibular bone alterations based on imaging examinations in MM patients treated with bisphosphonates. The selected studies were quali tatively assessed using the Critical Appraisal Tools from SUMARI. Results : Six studies, involving 669 MM patients, were included, with 447 receiving bisphosphonate treatment. The majority were treated with pamidronate, zoledronate, or a combination of both. Seventy patients developed medicationrelated osteonecrosis of the jaw (MRONJ), predominantly in the mandible, characterized by the presence of bony sequestrum, bone sclerosis, increased periodontal ligament space, osteolytic lesions, and osteomyelitis as observed in imaging analyses. For nonMRONJ lesions, the mandible also exhibited the highest frequency of asymptomatic bone alterations. These ranged from "punchedout" osteolytic lesions or "soap bubble" lesions to solitary bone lesions, areas of bone sclerosis, abnormalities of the hard palate, osteoporosis, nonhealed alveoli, and cortical bone rupture. Conclusion : MM patients treated with bisphosphonates display radiographic patterns of maxillomandibular bone lesions. These patterns aid in diagnosis and facilitate early and targeted treatment, thereby contributing to improved morbidity outcomes for these patients. (Imaging Sci Dent 20240032)
引用
收藏
页码:221 / 231
页数:11
相关论文
共 50 条
  • [31] Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma
    Avigdor, A
    Raanani, P
    Levi, I
    Hardan, I
    Ben-Bassat, I
    LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 683 - +
  • [32] Biochemical bone markers in patients with multiple myeloma
    Nawawi, H
    Samson, D
    Apperley, J
    Girgis, S
    CLINICA CHIMICA ACTA, 1996, 253 (1-2) : 61 - 77
  • [33] Modern Imaging Techniques in Patients with Multiple Myeloma
    Bannas, P.
    Kroeger, N.
    Adam, G.
    Derlin, T.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2013, 185 (01): : 26 - 33
  • [34] Bortezomib in multiple myeloma: systematic review and clinical considerations
    Kouroukis, T. C.
    Baldassarre, F. G.
    Haynes, A. E.
    Imrie, K.
    Reece, D. E.
    Cheung, M. C.
    CURRENT ONCOLOGY, 2014, 21 (04) : E573 - E603
  • [35] Soluble molecules and bone metabolism in multiple myeloma: a review
    Zoppoli, Gabriele
    Balleari, Enrico
    Ghio, Riccardo
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2008, 5 (01) : 67 - 70
  • [36] State-of-the-art of bone marrow imaging in multiple myeloma
    Marti-Bonmati, Luis
    Ramirez-Fuentes, Cristina
    Alberich-Bayarri, Angel
    Ruiz-Llorca, Cristina
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (06) : 540 - 550
  • [37] A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of Hematological Toxicities in Patients with Multiple Myeloma Treated with Daratumumab
    Win, Myint
    Thein, Kyaw
    Phyu, Ei
    Han, Myat
    D'Cunha, Nicholas
    Tijani, Lukman
    Currie, Mark
    Quick, Donald
    Pendergrast, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S243
  • [38] Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review
    Mainou, Maria
    Tsapa, Kalliopi
    Michailidis, Theodoros
    Malandris, Konstantinos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Liakos, Aris
    Papaioannou, Maria
    Terpos, Evangelos
    Prasad, Vinay
    Tsapas, Apostolos
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 204
  • [39] A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma
    Hicks, Lisa K.
    Haynes, Adam E.
    Reece, Donna E.
    Walker, Irwin R.
    Herst, Jordan A.
    Meyer, Ralph M.
    Imrie, Kevin
    CANCER TREATMENT REVIEWS, 2008, 34 (05) : 442 - 452
  • [40] Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma
    Moulopoulos, LA
    Gika, D
    Anagnostopoulos, A
    Delasalle, K
    Weber, D
    Alexanian, R
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (11) : 1824 - 1828